Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnicorn Asset Management Regulatory News (UAV)

Share Price Information for Unicorn Asset Management (UAV)

Share Price is delayed by 15 minutes
Get Live Data
70.00    0.00 (0.00%)
Bid:
67.00
Ask:
73.00
Spread: 6.00 (8.955%)
Market Cap: £180.27m
UAV Live PriceLast checked at - London Stock Exchange

Intraday Unicorn Asset Management Share Chart

Portfolio Update

28 Nov 2025 13:34

RNS Number : 4934J
Unicorn AIM VCT PLC
28 November 2025
 

Unicorn AIM VCT PLC

LEI: 21380057QDV7D34E9870

Portfolio Update

 

The Directors of Unicorn AIM VCT plc (the "Company") are pleased to announce that the Company, together with other shareholders of Hasgrove Limited ("Hasgrove"), has entered into an agreement with Castik Capital S.à r.l. ("Castik") in connection with Castik's proposed acquisition of a majority stake in Hasgrove.

 

As part of the transaction, Unicorn AIM VCT plc, together with the former Chairman and members of the executive management team, will realise a portion of their investment for cash and, alongside Castik, will become shareholders in a new holding company established to acquire Hasgrove (the "Newco").

 

Hasgrove is currently the largest holding in the Company's portfolio and was most recently valued at £46.7 million in the Company's Net Asset Value ("NAV") update released as at 31 October 2025. Subject to completion of the transaction, receipt of the cash consideration and the finalisation of valuations, the Board expects the NAV to be materially higher than that reported as at 31 October 2025. In connection with the Transaction, the Company will conduct a fair value review of its interest in Newco and publish an updated NAV as soon as practicable.

 

The Company expects to receive total net proceeds of approximately £87 million from the transaction. Of this amount, approximately £22 million is expected to be settled through the issuance of shares in Newco, with the remaining £65m expected to be received in cash (in each case subject to completion adjustments). The Board will consider whether to declare a special dividend following completion and once final proceeds have been received, with further details (including quantum and timing) to be announced in due course.

 

Unicorn Asset Management Limited ("Unicorn"), the Company's Investment Manager, commented:

 

"Unicorn has been proud to partner with Hasgrove since backing the business at IPO in 2006, providing strategic input and working closely with the leadership team throughout its journey. This transaction delivers another significant realisation for Unicorn AIM VCT plc shareholders, crystallising significant value whilst crucially maintaining exposure to what we believe is a high-quality, cash-generative business with strong growth potential. Having engaged closely with both management and Castik, we are confident this partnership represents the right next step and look forward to working together as Hasgrove enters this exciting new chapter."

 

Tim Woodcock, Chair, Unicorn AIM VCT plc. commented:

 

"The Unicorn team have delivered an excellent result in both realising considerable cash proceeds from the investment for the Company's shareholders, and negotiating a deal which enables the VCT to participate in the future growth of Hasgrove"

 

For further information please contact:

 

Investment Manager:

Unicorn Asset Management Limited

Telephone: 020 7253 0889

Email:info@unicornam.com

 

Company Secretary:

ISCA Administration Services Limited

Telephone: 01392 487056

Email:unicornaimvct@iscaadmin.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUXVLFLEFLXFBL
Date   Source Headline
5th Jun 20261:06 pmRNSNet Asset Value(s)
1st Jun 202610:50 amRNSTotal Voting Rights
20th May 202610:06 amRNSIssue of Equity
15th May 202610:33 amRNSAppointment of Director
6th May 20262:01 pmRNSNet Asset Value(s)
1st May 202610:07 amRNSTotal Voting Rights
1st Apr 20264:20 pmRNSNet Asset Value(s)
1st Apr 20268:22 amRNSTotal Voting Rights
12th Mar 20267:00 amRNSOffer for Subscription Update - Overallotment
10th Mar 20265:10 pmRNSTransaction in Own Shares
10th Mar 20265:10 pmRNSTransaction in Own Shares
6th Mar 20267:00 amRNSIssue of Equity
5th Mar 20262:12 pmRNSIssue of Equity
4th Mar 20265:49 pmRNSNet Asset Value(s)
3rd Mar 20262:17 pmRNSNet Asset Value(s)
2nd Mar 20267:00 amRNSTotal Voting Rights
18th Feb 20264:23 pmRNSTransaction in Own Shares
13th Feb 20267:00 amRNSIssue of Equity
6th Feb 202612:01 pmRNSNet Asset Value(s)
4th Feb 20264:34 pmRNSResult of AGM
26th Jan 20264:19 pmRNSOffer for Subscription and Issue of Offer Document
15th Jan 20263:57 pmRNSDividend Declaration
14th Jan 20262:33 pmRNSNet Asset Value(s)
22nd Dec 20254:28 pmRNSPortfolio Update
22nd Dec 20254:28 pmRNSPortfolio Update
10th Dec 20252:24 pmRNSNet Asset Value(s)
5th Dec 20257:12 amRNSDirector Declaration
5th Dec 20257:00 amRNSFinal Results
28th Nov 20251:34 pmRNSPortfolio Update
27th Nov 20257:00 amRNSStatement re Intention to Launch an Offer
6th Nov 20257:00 amRNSNet Asset Value(s)
13th Oct 20254:28 pmRNSNet Asset Value(s)
2nd Sep 202511:22 amRNSNet Asset Value(s)
1st Sep 20259:30 amRNSTotal Voting Rights
14th Aug 20254:57 pmRNSTransaction in Own Shares
12th Aug 20254:13 pmRNSDirector/PDMR Shareholding
12th Aug 202510:27 amRNSIssue of Equity under DRIS
6th Aug 202511:08 amRNSNet Asset Value(s)
1st Aug 20259:02 amRNSTotal Voting Rights
22nd Jul 202510:03 amRNSTransaction in Own Shares
4th Jul 202511:55 amRNSNet Asset Value(s)
1st Jul 20259:33 amRNSTotal Voting Rights
18th Jun 20254:44 pmRNSTransaction in Own Shares
3rd Jun 20251:57 pmRNSNet Asset Value(s)
20th May 20257:00 amRNSHalf-year Report
6th May 20253:24 pmRNSNet Asset Value(s)
15th Apr 20259:48 amRNSIssue of Equity
15th Apr 20257:00 amRNSNet Asset Value(s)
4th Apr 20257:00 amRNSIssue of Equity
1st Apr 20254:23 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.